Paul de Jonge

Paul de Jonge currently serves as a Senior Scientist and Deputy Head of the Cell Therapy Facility at Radboudumc, where responsibilities include the clinical translation and pre-clinical development of natural killer cell immunotherapy for cancer, as well as stem cell transplantation and cellular immunotherapy. Prior experience includes roles as a postdoctoral researcher focused on natural killer cell therapy and as a PhD candidate developing medical devices for urogenital tissue engineering. Paul de Jonge's leadership skills were evidenced during tenure as Chairman of the conference committee for the NVvTG, organizing significant conferences in healthcare technology. Concurrently, entrepreneurial experience was gained as co-founder of Antiziq V.O.F., alongside editorial experience with the magazine "Parallaks." Educational qualifications encompass a Master of Science and Bachelor of Science in Technical Medicine from the University of Twente.